Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cfe2eef6bbcf3e90db3242489713f5f9 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
filingDate |
2019-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a020ed4734ba3015544a06db88f15e9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9cf6263ec2b87eadf12509eb590e28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a68d78cda96d4f19a7a1e688cf7a7e11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dc17d49596b8af77c3de66da5b2c59c |
publicationDate |
2021-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20210086661-A |
titleOfInvention |
Arylsulfonylpyrrolecarboxamide derivatives as Kv3 potassium channel activators |
abstract |
The present invention provides novel compounds that activate Kv3 potassium channels. The compound has the structure (Formula I). [Formula I] A separate aspect of the invention relates to pharmaceutical compositions comprising said compounds and to the use of the compounds for the treatment of disorders responsive to activation of Kv3 potassium channels. |
priorityDate |
2018-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |